Basics Invivyd, Inc. IPO Date: August 6, 2022 Sector: Healthcare Industry: Biotech Market Cap: $107.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.09 | 5.17% Avg Daily Range (30 D): $0.04 | 5.56% Avg Daily Range (90 D): $0.08 | 8.96% Institutional Daily Volume Avg Daily Volume: 1.59M Avg Daily Volume (30 D): 1.86M Avg Daily Volume (90 D): 8.83M Trade Size Avg Trade Size (Sh.): 318 Avg Trade Size (Sh.) (30 D): 412 Avg Trade Size (Sh.) (90 D): 478 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $2.72M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.68M Avg Inst. Trade Volume: 1.06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.12M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $.55M Avg Closing Volume: 2.15M         News Mar 20, 2025 @ 12:01 PM Invivyd Reports Fourth Quarter and Full-Year 2024 ... Source: N/A Nov 6, 2024 @ 1:01 PM Invivyd to Participate in the Guggenheim Securitie... Source: N/A Nov 6, 2024 @ 12:01 PM Invivyd to Host Third Quarter 2024 Financial Resul... Source: N/A Oct 16, 2024 @ 11:01 AM Invivyd to Present PEMGARDAâ„¢ (pemivibart) Da... Source: Globe Newswire Jul 1, 2024 @ 11:01 AM Invivyd Announces its Addition to the Russell 2000... Source: Invivyd Financials   TTM Q4 2024 FY 2024 Basic EPS $-.14 $-.15 $-1.43 Diluted EPS $-.14 $-.15 $-1.43 Revenue $ 11.3M $ 13.82M $ 25.38M Gross Profit $ $ $ Net Income / Loss $ -16.29M $ -18.44M $ -169.93M Operating Income / Loss $ -16.92M $ -19.23M $ -176.88M Cost of Revenue $ $ $ Net Cash Flow $ -21.26M $ -37.53M $ -131.3M PE Ratio